{"id":5659,"date":"2015-12-09T15:51:20","date_gmt":"2015-12-09T20:51:20","guid":{"rendered":"http:\/\/localhost:10028\/practiceareas\/testosterone\/"},"modified":"2022-06-21T16:54:02","modified_gmt":"2022-06-21T20:54:02","slug":"testosteron","status":"publish","type":"practiceareas","link":"https:\/\/napolilaw.lemonadestand.org\/de\/praxisbereiche-2\/testosteron\/","title":{"rendered":"Testosterone"},"content":{"rendered":"<p>Niedriger Testosteronspiegel, umgangssprachlich Low-t genannt, ist eine der am h\u00e4ufigsten diagnostizierten Erkrankungen bei alternden M\u00e4nnern. Zus\u00e4tzlich zu Bedenken dar\u00fcber, ob diejenigen, bei denen die Erkrankung diagnostiziert wird, tats\u00e4chlich darunter leiden (oder nur normale altersbedingte Symptome haben), k\u00f6nnen Medikamente, die zur Behandlung von niedrigem t hergestellt werden, gef\u00e4hrlich sein. Wenn bei Ihnen ein niedriger Testosteronspiegel diagnostiziert wurde und Ihnen Low-t-Medikamente verschrieben wurden,<em> oder<\/em> Wenn Sie Testosteron-Injektionen oder -Pillen zur Behandlung von verz\u00f6gerter Pubert\u00e4t, Impotenz oder Brustkrebs eingenommen haben, m\u00fcssen Sie Folgendes wissen:<\/p>\n<p>&nbsp;<\/p>\n<h3>Die Risiken von Testosteron-Medikamenten<\/h3>\n<p>M\u00e4nnern werden oft Low-t-Medikamente verschrieben, um \u201eLifestyle\u201c-Probleme und nicht medizinische Probleme zu behandeln. Und das <a href=\"http:\/\/www.wsj.com\/articles\/fda-panel-recommends-more-study-on-testosterone-drugs-for-low-t-use-1410994105\" target=\"_blank\" rel=\"noopener\">Die Risiken der Einnahme von Low-t-Medikamenten sind vielf\u00e4ltig<\/a> \u2013 Studien weisen darauf hin, dass die Einnahme eines niedrigen Testosteronspiegels das Risiko eines Mannes f\u00fcr Folgendes erh\u00f6hen kann:<\/p>\n<ul>\n<li>Herzinfarkt;<\/li>\n<li>Schlaganfall; Und<\/li>\n<li>Tod.<\/li>\n<\/ul>\n<p>In fact, in March of 2015, the U.S. Food &amp; Drug Administration (FDA) issued a safety announcement cautioning against the use of low-t drugs for aging, and requiring low-t drug manufacturers to change labels on their products to include risks of heart attack and stroke.<\/p>\n<p>Testosterone injections may also be given to women who are suffering from breast cancer, or to men or boys who are suffering from symptoms caused by a lack of the hormone (delayed puberty, erectile dysfunction, etc.) However, testosterone injections, pellets, and pills have been associated with emotional changes, changes in sexual function, changes in sleep patterns, gynecomastia, and more.<\/p>\n<p>&nbsp;<\/p>\n<h3>Was muss ich \u00fcber die Einreichung einer Klage wissen?<\/h3>\n<p><a href=\"http:\/\/www.accessdata.fda.gov\/scripts\/cder\/drugsatfda\/index.cfm?fuseaction=Search.SearchAction&amp;SearchType=BasicSearch&amp;searchTerm=testosterone&amp;Search_Button=Submit\" target=\"_blank\" rel=\"noopener\">Low-t-Medikamente und Testosterontherapie<\/a> can be very dangerous for a patient. If you have suffered harm as a result of either, you may have the right to civil action. To help you understand whether or not you are entitled to file a suit and reclaim damages, and how to file a lawsuit directly against a dangerous drug\u2019s manufacturer, you need an attorney.<\/p>\n<p>At Napoli Shkolnik, PLLC, our experienced <a href=\"\/de\/praxisbereiche-2\/pharma-rechtsstreitigkeiten\/\">pharmazeutische Rechtsstreitigkeiten<\/a> Team ist bereit, f\u00fcr Sie zu schlagen. Um mehr zu erfahren, vereinbaren Sie noch heute einen Beratungstermin mit uns, um Ihren Fall zu besprechen.<\/p>","protected":false},"excerpt":{"rendered":"<p>Low testosterone, colloquially called low-t, is one of the most commonly diagnosed medical conditions amongst aging men. However, in addition to concerns about whether those who are diagnosed with the&#8230;<\/p>","protected":false},"featured_media":0,"menu_order":194,"template":"","practiceareas_category":[743],"class_list":["post-5659","practiceareas","type-practiceareas","status-publish","hentry","practiceareas_category-pharmaceutical-litigation"],"acf":[],"_links":{"self":[{"href":"https:\/\/napolilaw.lemonadestand.org\/de\/wp-json\/wp\/v2\/practiceareas\/5659","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/napolilaw.lemonadestand.org\/de\/wp-json\/wp\/v2\/practiceareas"}],"about":[{"href":"https:\/\/napolilaw.lemonadestand.org\/de\/wp-json\/wp\/v2\/types\/practiceareas"}],"version-history":[{"count":0,"href":"https:\/\/napolilaw.lemonadestand.org\/de\/wp-json\/wp\/v2\/practiceareas\/5659\/revisions"}],"wp:attachment":[{"href":"https:\/\/napolilaw.lemonadestand.org\/de\/wp-json\/wp\/v2\/media?parent=5659"}],"wp:term":[{"taxonomy":"practiceareas_category","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/de\/wp-json\/wp\/v2\/practiceareas_category?post=5659"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}